MAB885
Anti-Papillomavirus Antibody, 16L1, late protein, clone Cam Vir-1
clone Cam Vir-1, Chemicon®, from mouse
Sinonimo/i:
HPV
Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
About This Item
Codice UNSPSC:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Prodotti consigliati
Origine biologica
mouse
Livello qualitativo
Forma dell’anticorpo
purified antibody
Tipo di anticorpo
primary antibodies
Clone
Cam Vir-1, monoclonal
Reattività contro le specie
human
Produttore/marchio commerciale
Chemicon®
tecniche
immunohistochemistry: suitable (paraffin)
immunoprecipitation (IP): suitable
western blot: suitable
Isotipo
IgG2a
Condizioni di spedizione
wet ice
Specificità
L1 (late) protein of Human Papilloma Virus type 16. Useful for studies of HPV in cervical smears and biopsies. Recognizes HPV-16 L1 by immunoprecipitation, western blotting and immunofluorescence on cells fixed in acetone or paraformaldehyde and immunoperoxidase staining of paraffin sections.
Immunogeno
Beta galactosidase-HPV L1 fusion protein containing the c-terminal 60% of the L1 sequence.
Epitope: 16L1, Late Protein
Applicazioni
Anti-Papillomavirus Antibody, 16L1, late protein, clone Cam Vir-1 detects level of Papillomavirus & has been published & validated for use in IP, WB, IH(P).
Immunoprecipitation, western blotting and immunofluorescence.
Immunohistochemistry.
Shows reactivity on fixed tissue. Dilute with buffer pH 7.5 -8.0 to desired working volumes. For extensive dilution, protein containing or other stabilizing medium should be used. Final working dilutions must be determined by end user.
Immunohistochemistry.
Shows reactivity on fixed tissue. Dilute with buffer pH 7.5 -8.0 to desired working volumes. For extensive dilution, protein containing or other stabilizing medium should be used. Final working dilutions must be determined by end user.
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
Stato fisico
Format: Purified
Liquid in phosphate buffer saline (PBS), pH 7.4 with 0.1% sodium azide.
Stoccaggio e stabilità
Maintain at -20°C for up to 12 months. Avoid repeated freeze/thaw cycles.
Altre note
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Note legali
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Esclusione di responsabilità
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Non trovi il prodotto giusto?
Prova il nostro Motore di ricerca dei prodotti.
Codice della classe di stoccaggio
10 - Combustible liquids
Classe di pericolosità dell'acqua (WGK)
WGK 2
Punto d’infiammabilità (°F)
Not applicable
Punto d’infiammabilità (°C)
Not applicable
Certificati d'analisi (COA)
Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
Analysis of the L1 gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinant.
Browne, H M, et al.
The Journal of General Virology, 69 ( Pt 6), 1263-1273 (1988)
Seroprevalence of seven high-risk HPV types in The Netherlands.
Mirte Scherpenisse,Madelief Mollers,Rutger M Schepp,Hein J Boot,Hester E de Melker et al.
Vaccine null
Xue Chen et al.
Human vaccines & immunotherapeutics, 14(8), 2025-2033 (2018-04-24)
Current available human papillomavirus (HPV) vaccines are based on the major capsid protein L1 virus-like particles (VLPs), which mainly induce type-specific neutralizing antibodies against vaccine types. Continuing to add more types of VLPs in a vaccine raises the complexity and
Anthony V Morante et al.
Microbiology spectrum, 10(3), e0150522-e0150522 (2022-05-25)
Human papillomaviruses (HPVs) consist of two capsid proteins: major capsid protein L1 and minor capsid protein L2. The L2 protein has been shown to be involved in intracellular trafficking events that lead to the deposition of the viral DNA into
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica.